Evidence map›Paper›PMID 27535995›Full record

ArticleBlood2016

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes.

Peter L Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo Garcia-Manero, Francesc Solé, John M Bennett, David Bowen, Pierre Fenaux, Francois Dreyfus and 24 more

Abstract readLetterComment
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Myelodysplastic Syndrome: Diagnosis and Screening.Diagnostics (Basel, Switzerland) · 2022
    Review
  11. When are idiopathic and clonal cytopenias of unknown significance (ICUS or CCUS)?Hematology. American Society of Hematology. Education Program · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

34 authors.

Peter L GreenbergStanford University Cancer Institute, Stanford, CA.
Heinz TuechlerHanusch Hospital, Boltzmann Institute for Leukemia Research, Vienna, Austria.
Julie SchanzGeorg August Universität, Göttingen, Germany.
Guillermo SanzHospital Universitario La Fe, Valencia, Spain.
Guillermo Garcia-ManeroUniversity of Texas, MD Anderson Cancer Center, Houston, TX.
Francesc SoléHospital del Mar, Barcelona, Spain.
John M BennettUniversity of Rochester Medical Center, James P. Wilmot Cancer Center, Rochester, NY.
David BowenSt. James's University Hospital, Leeds, United Kingdom.
Pierre FenauxHôpital Avicenne, Assistance Publique-Hôpitaux de Paris(AP-HP)/University Paris XIII, Bobigny, France.
Francois DreyfusHôpital Cochin, AP-HP/University Paris V, Paris, France.
Hagop KantarjianUniversity of Texas, MD Anderson Cancer Center, Houston, TX.
Andrea KuendgenHeinrich-Heine University Hospital, Düsseldorf, Germany.
Alessandro LevisAntonio e Biagio e C Arrigo Hospital, Alessandria, Italy.
Luca MalcovatiFondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy.
Mario CazzolaFondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo and University of Pavia, Pavia, Italy.
Jaroslav CermakInstitute of Hematology and Blood Transfusion, Praha, Czech Republic.
Christa FonatschMedical University of Vienna, Vienna, Austria.
Michelle M Le BeauThe University of Chicago Comprehensive Cancer Research Center, Chicago, IL.
Marilyn L SlovakQuest Diagnostics Nichols Institute, Chantilly, VA.
Otto KriegerElisabethinen Hospital, Linz, Austria.
Michael LuebbertUniversity of Freiburg Medical Center, Freiburg, Germany.
Jaroslaw MaciejewskiCleveland Clinic, Cleveland, OH.
Silvia M M MagalhaesFederal University of Ceara, Fortaleza, Brazil.
Yasushi MiyazakiNagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Michael PfeilstöckerHanusch Hospital, Boltzmann Institute for Leukemia Research, Vienna, Austria.
Mikkael SekeresCleveland Clinic, Cleveland, OH.
Wolfgang R SperrMedical University of Vienna, Vienna, Austria.
Reinhard StauderUniversity Hospital of Innsbruck, Innsbruck, Austria.
Sudhir TauroUniversity of Dundee, Scotland, United Kingdom.
Peter ValentMedical University of Vienna, Vienna, Austria.
Teresa VallespiHospital Universitario Vall d'Hebron, Barcelona, Spain; and.
Arjan A van de LoosdrechtVU University Medical Center, Amsterdam, The Netherlands.
Ulrich GermingHeinrich-Heine University Hospital, Düsseldorf, Germany.
Detlef HaaseGeorg August Universität, Göttingen, Germany.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kathrin Milbury · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnemiaMyelodysplastic SyndromesHumansLeukopeniaThrombocytopenia

Identifiers

PMID27535995
PMCPMC5341483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.